Clinical Trial Update: Treatment of Adults With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial led by LG Life Sciences evaluating treatment for adults with growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Snippet

Sponsor: LG Life Sciences | Conditions: Pituitary Disorders, Adult Growth Hormone Deficiency | Phase 3 | Status: COMPLETED